Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
We conducted a screening of anti-HLA antibodies for patients who underwent pediatric living donor liver transplantation. In this study, we found that CNI minimization or withdrawal was an independent risk factor for DSA development and that the association between younger age and DSA development was related to reduced CNI dose for recipient growth. Additionally, subgroup analyses for patients with anti-DQ DSAs available showed that low-trough CNI was an independent risk factor for anti-class II DSA development, and that almost all high-MFI DSAs had complement-binding ability.
|